Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RAPP Rapport Therapeutics, Inc.

休市中 01-03 16:00:00 EST

19.48

+1.09

+5.93%

盘后19.48

+0.000.00%

16:01 EST

最高19.61	最低18.15	成交量10.87万
今开18.62	昨收18.39	日振幅7.94%
总市值7.13亿	流通市值2.89亿	总股本3,658万
成交额205.37万	换手率0.73%	流通股本1,483万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":19.48,"timestamp":1735938000000,"preClose":18.39,"halted":0,"volume":108688,"hourTrading":{"tag":"盘后","latestPrice":19.48,"preClose":19.48,"latestTime":"16:01 EST","volume":346,"amount":6740.08,"timestamp":1735938062028},"delay":0,"floatShares":14829280,"shares":36576457,"eps":-5.809674,"marketStatus":"休市中","change":1.09,"latestTime":"01-03 16:00:00 EST","open":18.62,"high":19.61,"low":18.15,"amount":2053708.12616,"amplitude":0.079391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.809674,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1736154000000},"marketStatusCode":7,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":18.39,"preHourTrading":{"tag":"盘前","latestPrice":18.59,"preClose":18.39,"latestTime":"08:38 EST","volume":246,"amount":4584.060432,"timestamp":1735911498003},"postHourTrading":{"tag":"盘后","latestPrice":19.48,"preClose":19.48,"latestTime":"16:01 EST","volume":346,"amount":6740.08,"timestamp":1735938062028},"volumeRatio":1.374708,"impliedVol":0.5402,"impliedVolPercentile":0.5517},"requestUrl":"/m/hq/s/RAPP","defaultTab":"news","newsList":[{"id":"2500897887","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500897887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500897887?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:08","pubTimestamp":1735830539,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时08分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.02%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501022309009859049a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501022309009859049a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2500612329","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500612329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500612329?lang=zh_cn&edition=full","pubTime":"2025-01-01 00:08","pubTimestamp":1735661300,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日00时08分，Rapport Therapeutics, Inc.股票出现波动，股价快速下挫5.90%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，知临集团、Onconetix, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为2334.70%、1245.52%、261.70%，振幅较大的相关个股有Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、知临集团，振幅分别为265.45%、248.39%、119.56%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010008209856a4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010008209856a4ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","RAPP","BK4139"],"gpt_icon":0},{"id":"2494335664","title":"Rapport Therapeutics, Inc.盘中异动 快速跳水5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494335664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494335664?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:34","pubTimestamp":1735320851,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时34分，Rapport Therapeutics, Inc.股票出现异动，股价急速下跌5.96%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Abpro Holdings, Inc、Vor Biopharma Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Neuphoria Therapeutics Inc.较为活跃，换手率分别为120.82%、58.80%、51.76%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Galectin Therapeutics Inc.、Abpro Holdings, Inc，振幅分别为147.50%、65.39%、62.45%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280134119851f8f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412280134119851f8f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RAPP","BK4007"],"gpt_icon":0},{"id":"2493761667","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493761667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493761667?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:09","pubTimestamp":1734966577,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时09分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌5.37%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Traws Pharma, Inc.、Gt Biopharma, Inc.较为活跃，换手率分别为765.30%、522.68%、510.17%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为116.73%、104.19%、57.92%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122323093795eadca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122323093795eadca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2493421329","title":"Rapport Therapeutics, Inc.盘中异动 快速拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493421329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493421329?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:15","pubTimestamp":1734714929,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时15分，Rapport Therapeutics, Inc.股票出现异动，股价大幅上涨5.54%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221011529ab87a95b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221011529ab87a95b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2492038581","title":"Rapport Therapeutics, Inc.盘中异动 早盘大幅下挫5.30%报17.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492038581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492038581?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:36","pubTimestamp":1734622607,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时36分，Rapport Therapeutics, Inc.股票出现波动，股价大幅跳水5.30%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219233647984cdabf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219233647984cdabf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","RAPP"],"gpt_icon":0},{"id":"2492996240","title":"Rapport Therapeutics, Inc.盘中异动 大幅拉升5.12%报19.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492996240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492996240?lang=zh_cn&edition=full","pubTime":"2024-12-18 02:26","pubTimestamp":1734460006,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日02时26分，Rapport Therapeutics, Inc.股票出现波动，股价大幅拉升5.12%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Portage Biotech Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.涨幅较大，Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Polyrizon Ltd.较为活跃，换手率分别为2950.43%、398.35%、153.52%，振幅较大的相关个股有Portage Biotech Inc.、Tonix Pharmaceuticals Holding Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为211.53%、157.92%、96.08%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218022646984c9366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218022646984c9366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2492610379","title":"Rapport Therapeutics, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492610379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492610379?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:44","pubTimestamp":1734371050,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时44分，Rapport Therapeutics, Inc.股票出现波动，股价急速拉升5.01%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217014410984c741b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217014410984c741b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","RAPP","BK4139"],"gpt_icon":0},{"id":"2491037290","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大跌5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491037290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491037290?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:05","pubTimestamp":1734105931,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时05分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌5.94%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214000531ab75b7d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214000531ab75b7d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2490382477","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.68%报19.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490382477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490382477?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:49","pubTimestamp":1734014976,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时49分，Rapport Therapeutics, Inc.股票出现波动，股价大幅下跌5.68%。截至发稿，该股报19.10美元/股，成交量2826股，换手率0.01%，振幅5.53%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224936a1e95a57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212224936a1e95a57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2489965234","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489965234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489965234?lang=zh_cn&edition=full","pubTime":"2024-12-06 02:23","pubTimestamp":1733423001,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日02时23分，Rapport Therapeutics, Inc.股票出现异动，股价大幅跳水5.52%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Protara Therapeutics, Inc.、Molecular Templates, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3534.45%、2330.76%、490.88%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Molecular Templates, Inc.、Protara Therapeutics, Inc.，振幅分别为136.00%、124.83%、106.21%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206022321971beace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206022321971beace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RAPP","BK4007"],"gpt_icon":0},{"id":"2488947617","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488947617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488947617?lang=zh_cn&edition=full","pubTime":"2024-12-04 00:07","pubTimestamp":1733242064,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日00时07分，Rapport Therapeutics, Inc.股票出现异动，股价急速下跌5.00%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204000744abf328f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204000744abf328f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","RAPP"],"gpt_icon":0},{"id":"2488985286","title":"Rapport Therapeutics, Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488985286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488985286?lang=zh_cn&edition=full","pubTime":"2024-12-03 04:52","pubTimestamp":1733172775,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日04时52分，Rapport Therapeutics, Inc.股票出现异动，股价快速拉升5.17%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3020.04%、2784.78%、673.71%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203045255a26747dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203045255a26747dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4139","BK4007"],"gpt_icon":0},{"id":"2486970820","title":"Rapport Therapeutics, Inc.盘中异动 早盘大幅拉升7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486970820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486970820?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:32","pubTimestamp":1732717936,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时32分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨7.21%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为794.97%、26.44%、6.89%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Silexion Therapeutics Corp，振幅分别为19.11%、13.97%、10.87%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223217971a8dcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223217971a8dcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPP","BK4007","BK4139"],"gpt_icon":0},{"id":"2486574750","title":"Rapport Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486574750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486574750?lang=zh_cn&edition=full","pubTime":"2024-11-26 04:39","pubTimestamp":1732567158,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日04时39分，Rapport Therapeutics, Inc.股票出现波动，股价快速下挫5.00%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126043918971a8749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126043918971a8749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","RAPP"],"gpt_icon":0},{"id":"2485641736","title":"Rapport Therapeutics, Inc.盘中异动 大幅拉升5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485641736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485641736?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:03","pubTimestamp":1732208588,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时03分，Rapport Therapeutics, Inc.股票出现异动，股价急速上涨5.64%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Briacell Therapeutics Corp.、Cidara Therapeutics, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为914.35%、497.20%、364.61%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010309971a7ee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122010309971a7ee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RAPP","BK4007"],"gpt_icon":0},{"id":"2484971729","title":"Rapport Therapeutics, Inc.盘中异动 急速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484971729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484971729?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:50","pubTimestamp":1732042217,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时50分，Rapport Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Syros Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1068.84%、836.88%、146.46%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.，振幅分别为91.10%、81.67%、68.54%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025017971a7805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025017971a7805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2484606905","title":"Rapport Therapeutics, Inc.盘中异动 急速拉升5.16%报22.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484606905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484606905?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:19","pubTimestamp":1731950390,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时19分，Rapport Therapeutics, Inc.股票出现异动，股价快速拉升5.16%。截至发稿，该股报22.03美元/股，成交量3.5422万股，换手率0.10%，振幅4.75%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119011950a24373db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119011950a24373db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","RAPP","BK4139"],"gpt_icon":0},{"id":"2483377633","title":"Rapport Therapeutics, Inc.盘中异动 早盘股价大跌6.48%报20.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377633?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:49","pubTimestamp":1731682197,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时49分，Rapport Therapeutics, Inc.股票出现波动，股价快速下跌6.48%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224957971a6db4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224957971a6db4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPP","LENZ"],"gpt_icon":0},{"id":"2483855339","title":"Rapport Therapeutics, Inc.盘中异动 下午盘大幅下跌5.11%报23.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483855339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483855339?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:35","pubTimestamp":1731522927,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时35分，Rapport Therapeutics, Inc.股票出现异动，股价快速下跌5.11%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114023527abbe591e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114023527abbe591e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RAPP","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapportrx.com","stockEarnings":[{"period":"1week","weight":0.0236},{"period":"1month","weight":-0.0965},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.186},{"period":"1year","weight":0.1459},{"period":"ytd","weight":0.0981}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rapport Therapeutics, Inc.于2022年2月根据特拉华州法律注册成立，名称为Precision Neuroscience NewCo, Inc.，并于2022年10月更名为Rapport Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过发现和开发用于中枢神经系统（“CNS”）疾病患者的转化小分子药物，成为精确神经科学的领导者。","exchange":"NASDAQ","name":"Rapport Therapeutics, Inc.","nameEN":"Rapport Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rapport Therapeutics, Inc.,RAPP,Rapport Therapeutics, Inc.股票,Rapport Therapeutics, Inc.股票老虎,Rapport Therapeutics, Inc.股票老虎国际,Rapport Therapeutics, Inc.行情,Rapport Therapeutics, Inc.股票行情,Rapport Therapeutics, Inc.股价,Rapport Therapeutics, Inc.股市,Rapport Therapeutics, Inc.股票价格,Rapport Therapeutics, Inc.股票交易,Rapport Therapeutics, Inc.股票购买,Rapport Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rapport Therapeutics, Inc.(RAPP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rapport Therapeutics, Inc.(RAPP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}